BW

SHAREHOLDER ALERT – Labaton Sucharow Notifies CareDx, Inc. Investors of the Filing of a Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--Labaton Sucharow, a nationally ranked and award-winning shareholder rights firm, announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against CareDx, Inc. (“CareDx” or the “Company”) (NASDAQ: CDNA) and certain of its executive officers…
Leer más...

Baron & Budd Investigates Potential Cybersecurity Fraud Cases

Whistleblowers who have information about cybersecurity fraud may bring lawsuits under the False Claims Act. WASHINGTON--(BUSINESS WIRE)--Today, the national law firm Baron & Budd announced that it is dedicating significant resources from its whistleblower practice to investigate allegations of cybersecurity fraud. The U.S. Department of Justice is making the prosecution…
Leer más...

Oorwin Welcomes Luis Rivera as Chief Operating Officer (COO)

SAN FRANCISCO--(BUSINESS WIRE)--#AIATS--Oorwin is pleased to announce the appointment of Luis Rivera as Chief Operating Officer. Mr. Rivera joins Oorwin with more than 25 years of sales and operational experience in leading global companies. He has guided human resource technology companies through major transitions, such as initial public offerings, acquisitions…
Leer más...

Global Aesthetics Brand Hugel Inc. Accelerates the Leap Forward as a Global Company Appointing ‘Brent Saunders’, a World-Class Expert in the Medical Aesthetic Industry

The former Allergan Chairman and CEO and top medical aesthetics expert NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Hugel Inc., a global medical aesthetics company and South Korea’s leading company in the botulinum toxin and hyaluronic acid fillers market, announced to convene an extraordinary general shareholders’ meeting to appoint Brent Saunders to the Board…
Leer más...

Shasqi Appoints Steve Abella, M.D., as Chief Medical Officer and Scott Wieland, Ph.D., MBA, as SVP of Clinical Development

- Appointments bolster management team with expertise in clinical development strategy and execution - SAN FRANCISCO--(BUSINESS WIRE)--Shasqi, a clinical-stage biotechnology company developing click chemistry-activated oncology therapeutics, today announced the additions of Steve Abella, M.D., as Chief Medical Officer and Scott Wieland, Ph.D., MBA, as Senior Vice President of Clinical Development.…
Leer más...